Updates in Community Acquired Pneumonia (CAP) Treatment – Core EM
treatment of polymicrobial community-acquired pneumonia for ICU patients | Download Scientific Diagram
Community-Acquired Pneumonia
Community acquired pneumonia: assessment and treatment | RCP Journals
Community-Acquired Pneumonia: Empiric Antimicrobial Therapy | Consultant360
Everything You Need To Know About the New ATS/IDSA Community-Acquired Pneumonia Guidelines | FOAMid
Treatment of community-acquired pneumonia in adults who require hospitalization - UpToDate
Community Acquired Pneumonia (Adults) - HSE.ie
Antibacterial Drugs for Community-Acquired Pneumonia | The Medical Letter Inc.
Community Acquired Pneumonia (CAP) | FOAMcast
Preventing and Treating Community-Acquired Pneumonia: A Focus on Men
BTS guidelines for the management of community acquired pneumonia in adults: update 2009 | Thorax
Diagnosis and Treatment of Community-Acquired Pneumonia | AAFP
Community-Acquired Pneumonia in Adults: Diagnosis and Management | AAFP
Community Acquired Pneumonia (CAP) | FOAMcast
Severe community-acquired pneumonia - EMCrit Project
Updated Clinical Practice Guidelines for Community-Acquired Pneumonia
Community-Acquired Pneumonia (CAP) - Pneumonia - Respiratory Diseases - Diseases - McMaster Textbook of Internal Medicine
Overview | Pneumonia (community-acquired): antimicrobial prescribing | Guidance | NICE
Why does our local CAP guideline differ from Australian Therapeutic Guidelines? | AIMED - Let's talk about antibiotics
11: Community-Acquired Pneumonia: The Alveoli Strike Back - The Curbsiders
Community-Acquired Pneumonia: Empiric Antimicrobial Therapy | Consultant360
Community-Acquired Pneumonia in Adults (08.12.2017)
BTS guidelines for the management of community acquired pneumonia in adults: update 2009 | Thorax
Community-acquired pneumonia - The Lancet
Community Acquired Pneumonia - Inpatient and Outpatient ... | GrepMed
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial - The Lancet
